TL;DR
This review summarises the current role of 18F-FDG PET/CT in MM, with emphasis on initial diagnosis and disease extent evaluation, prognostic value, treatment response and MRD assessment, limitations and future perspectives.
Background: NUT carcinoma (NC) is a rare and highly aggressive NUTM1-rearranged malignancy characterized by rapid progression, frequent metastatic dissemination, and poor clinical outcomes. Evidence regarding the role of [18F]FDG PET/CT remains limited and is largely based on isolated case reports and small series. We...
Significant polymorphism of changes detected by 18 F-FDG PET/CT in MM patients at the diagnostic stage is demonstrated and will allow for the standardization of PET/CT result descriptions and increase the accuracy of their assessment during follow-up studies in the course of MM patient treatment.
Highlights What are the main findings? The %ΔSUVmax and the end-of-treatment Deauville score predicted survival in pediatric Burkitt lymphoma. Baseline SUVmax, MTV, and TLG showed only modest, estimated prognostic value in this cohort. What are the implications of the main findings? Dynamic metabolic response may be a...
Abstract Objectives The role of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) in monitoring basal cell carcinoma (BCC) during vismodegib therapy remains poorly defined, particularly in patients with extensive, multifocal, or Gorlin syndrome–associated disease. This study ai...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
